Principal Investigators

    Dr Catherine Lawrence


    University of Manchester

    Contact information of lead PI


    United Kingdom

    Title of project or programme

    Zinc deficiency drives inflammation-dependent cognitive decline in Alzheimer’s disease

    Source of funding information

    Alzheimer's Society

    Total sum awarded (Euro)

    € 350,882

    Start date of award


    Total duration of award in years



    Research Abstract

    Zinc (Zn2+) deficiency affects up to 2 billion people world-wide, and is particularly common in aged individuals. Low levels of Zn2+ are suggested to contribute to the worsening of Alzheimer’s disease (AD), and there is some evidence that dietary Zn2+ supplements may be protective. Inflammation is also known to contribute to the progression of AD. The NLRP3-inflammasome complex is one of the most important regulators of inflammation, and is central to the development of inflammation, pathology and memory deficits in a mouse model of AD. The overall aim of this research is to build upon our preliminary data establishing a link between Zn2+ deficiency and NLRP3 inflammasome activation. Using the APP/PS1 transgenic mouse model of AD we will examine the effects of a Zn2+ deficient diet on behaviour, memory and inflammation. We will breed APP/PS1 mice in which the gene for NLRP3 has been deleted and thus we will determine whether the effects of Zn2+ deficiency in the AD model occur via the NLRP3 inflammasome. The outcome of this research could be the realisation that there is a cohort of AD patients whose lives could be improved by the simple addition of a Zn2+ supplement to their diets. The experiments in this proposal may also provide further evidence that the process of inflammation represents a therapeutic target in AD.

    Further information available at:

Types: Investments < €500k
Member States: United Kingdom
Diseases: N/A
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF